Sun Pharma Advanced Research Company shares are locked at 10 percent upper circuit after the pharma research company received approval from USFDA for a drug used to treat epilepsy.
The size of the drug is USD 85 million. Also this is the first time the company has received net drug application (NDA) approval from the US.
Also Read - Taro inks drug pact
At 11:53 hours IST, the stock was quoting at Rs 131.90 amid hefty volumes on the Bombay Stock Exchange.
There were pending buy orders of 250,859 shares, with no sellers available while trading volumes increased six times to 273,290 shares as compared to its five-day average of 45,285 shares.
Anda sedang membaca artikel tentang
Sun Pharma Advanced Research soars 10% on USFDA nod for NDA
Dengan url
https://rokokkanker.blogspot.com/2013/09/sun-pharma-advanced-research-soars-10.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Sun Pharma Advanced Research soars 10% on USFDA nod for NDA
namun jangan lupa untuk meletakkan link
Sun Pharma Advanced Research soars 10% on USFDA nod for NDA
sebagai sumbernya
0 komentar:
Posting Komentar